account_balance
Investment manager · 13F filer · SEC CIK 1773195
Affinity Asset Advisors, LLC
Reported value$2.04Bas of Jun 30, 2026
Positions104 19 new, 10 sold out
Top 10 weight42.6%ROIV alone is 6%
FiledAug 1344 days after quarter end
Portfolio · as of Jun 30, 2026
Where the money is
New or addedTrimmedHeld
ROIVRoivant Sciences Ltd
6.5%Added +34%
APGEApogee Therapeutics Inc
6.4%Trimmed −23%
SYRESpyre Therapeutics Inc
5.6%
XENEXenon Pharmaceuticals Inc
4.7%Trimmed −5%
ERASErasca Inc
4.7%
INSMInsmed Inc
3.4%Added +35%
PRAXPraxis Precision Medicines I
3.0%Added +9%
ALKSAlkermes PLC
2.9%Trimmed −17%
ORKAOruka Therapeutics Inc
2.7%Added +18%
ANABAnaptysbio Inc
2.7%Trimmed −12%
AVTXAvalo Therapeutics Inc
2.6%Added +116%
CYTKCytokinetics Inc
2.3%Trimmed −21%
ROIVRoivant Sciences Ltd
6.5%Added +34%
APGEApogee Therapeutics Inc
6.4%Trimmed −23%
SYRESpyre Therapeutics Inc
5.6%
XENEXenon Pharmaceuticals Inc
4.7%Trimmed −5%
ERASErasca Inc
4.7%
INSM3.4%PRAX3.0%ALKS2.9%ORKA2.7%ANAB2.7%AVTX2.6%CYTK2.3%Boxes show the top 12 stocks, sized against each other. The bar above shows how much of the fund they are. 13F only covers US-listed stocks, so foreign holdings and short positions are missing.
Show the top 12 as a list
ROIV Roivant Sciences Ltd 6.5% Added +34%APGE Apogee Therapeutics Inc 6.4% Trimmed −23%SYRE Spyre Therapeutics Inc 5.6% HeldXENE Xenon Pharmaceuticals Inc 4.7% Trimmed −5%ERAS Erasca Inc 4.7% HeldINSM Insmed Inc 3.4% Added +35%PRAX Praxis Precision Medicines I 3.0% Added +9%ALKS Alkermes PLC 2.9% Trimmed −17%ORKA Oruka Therapeutics Inc 2.7% Added +18%ANAB Anaptysbio Inc 2.7% Trimmed −12%AVTX Avalo Therapeutics Inc 2.6% Added +116%CYTK Cytokinetics Inc 2.3% Trimmed −21%
What changed
Biggest moves since Mar 31, 2026
remove_circleSold out
- Centessa Pharmaceuticals PLC $55.6M
- Arcellx Inc $41.7M
- Terns Pharmaceuticals Inc $29.7M
- Ascendis Pharma A/s $21.7M